105 related articles for article (PubMed ID: 12965216)
1. Forced expression of cyclin D1 does not compensate for Id2 deficiency in the mammary gland.
Mori S; Inoshima K; Shima Y; Schmidt EV; Yokota Y
FEBS Lett; 2003 Sep; 551(1-3):123-7. PubMed ID: 12965216
[TBL] [Abstract][Full Text] [Related]
2. Wnt1 is epistatic to Id2 in inducing mammary hyperplasia, ductal side-branching, and tumors in the mouse.
Marino S; Romelfanger C; Yokota Y; Nusse R
BMC Cancer; 2004 Dec; 4():91. PubMed ID: 15601467
[TBL] [Abstract][Full Text] [Related]
3. Lactation defect in mice lacking the helix-loop-helix inhibitor Id2.
Mori S; Nishikawa SI; Yokota Y
EMBO J; 2000 Nov; 19(21):5772-81. PubMed ID: 11060028
[TBL] [Abstract][Full Text] [Related]
4. Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclins D1 and D2 binding to cdk4.
Said TK; Luo L; Medina D
Carcinogenesis; 1995 Oct; 16(10):2507-13. PubMed ID: 7586159
[TBL] [Abstract][Full Text] [Related]
5. Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells via Id2.
Kim NS; Kim HJ; Koo BK; Kwon MC; Kim YW; Cho Y; Yokota Y; Penninger JM; Kong YY
Mol Cell Biol; 2006 Feb; 26(3):1002-13. PubMed ID: 16428453
[TBL] [Abstract][Full Text] [Related]
6. Mammary epithelial cells are not able to undergo pregnancy-dependent differentiation in the absence of the helix-loop-helix inhibitor Id2.
Miyoshi K; Meyer B; Gruss P; Cui Y; Renou JP; Morgan FV; Smith GH; Reichenstein M; Shani M; Hennighausen L; Robinson GW
Mol Endocrinol; 2002 Dec; 16(12):2892-901. PubMed ID: 12456807
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of cyclin D2 and p27(Kip1) in cyclin D2 transgenic mouse mammary gland during development.
Kong G; Chua SS; Yijun Y; Kittrell F; Moraes RC; Medina D; Said TK
Oncogene; 2002 Oct; 21(47):7214-25. PubMed ID: 12370811
[TBL] [Abstract][Full Text] [Related]
9. Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice.
Lasorella A; Rothschild G; Yokota Y; Russell RG; Iavarone A
Mol Cell Biol; 2005 May; 25(9):3563-74. PubMed ID: 15831462
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Id2 expression by CCAAT/enhancer binding protein beta.
Karaya K; Mori S; Kimoto H; Shima Y; Tsuji Y; Kurooka H; Akira S; Yokota Y
Nucleic Acids Res; 2005; 33(6):1924-34. PubMed ID: 15809228
[TBL] [Abstract][Full Text] [Related]
11. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE
Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626
[TBL] [Abstract][Full Text] [Related]
12. Genetic replacement of cyclin D1 function in mouse development by cyclin D2.
Carthon BC; Neumann CA; Das M; Pawlyk B; Li T; Geng Y; Sicinski P
Mol Cell Biol; 2005 Feb; 25(3):1081-8. PubMed ID: 15657434
[TBL] [Abstract][Full Text] [Related]
13. Progesterone, in addition to estrogen, induces cyclin D1 expression in the murine mammary epithelial cell, in vivo.
Said TK; Conneely OM; Medina D; O'Malley BW; Lydon JP
Endocrinology; 1997 Sep; 138(9):3933-9. PubMed ID: 9275084
[TBL] [Abstract][Full Text] [Related]
14. Mammalian target of rapamycin regulates the growth of mammary epithelial cells through the inhibitor of deoxyribonucleic acid binding Id1 and their functional differentiation through Id2.
Jankiewicz M; Groner B; Desrivières S
Mol Endocrinol; 2006 Oct; 20(10):2369-81. PubMed ID: 16772532
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis.
Bagheri-Yarmand R; Talukder AH; Wang RA; Vadlamudi RK; Kumar R
Development; 2004 Jul; 131(14):3469-79. PubMed ID: 15226262
[TBL] [Abstract][Full Text] [Related]
16. In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.
Hosokawa Y; Papanikolaou A; Cardiff RD; Yoshimoto K; Bernstein M; Wang TC; Schmidt EV; Arnold A
Transgenic Res; 2001 Oct; 10(5):471-8. PubMed ID: 11708657
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle defects contribute to a block in hormone-induced mammary gland proliferation in CCAAT/enhancer-binding protein (C/EBPbeta)-null mice.
Grimm SL; Contreras A; Barcellos-Hoff MH; Rosen JM
J Biol Chem; 2005 Oct; 280(43):36301-9. PubMed ID: 16120603
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution.
Gadd M; Pisc C; Branda J; Ionescu-Tiba V; Nikolic Z; Yang C; Wang T; Shackleford GM; Cardiff RD; Schmidt EV
Cancer Res; 2001 Dec; 61(24):8811-9. PubMed ID: 11751403
[TBL] [Abstract][Full Text] [Related]
19. Impaired mammary gland development in Cyl-1(-/-) mice during pregnancy and lactation is epithelial cell autonomous.
Fantl V; Edwards PA; Steel JH; Vonderhaar BK; Dickson C
Dev Biol; 1999 Aug; 212(1):1-11. PubMed ID: 10419681
[TBL] [Abstract][Full Text] [Related]
20. Prolactin promotes mammary pathogenesis independently from cyclin D1.
Asher JM; O'Leary KA; Rugowski DE; Arendt LM; Schuler LA
Am J Pathol; 2012 Jul; 181(1):294-302. PubMed ID: 22658484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
